New drug for stroke prevention approved by NICE

Patients with atrial fibrillation can now be offered dabigatran (Pradaxa) in order to reduce the risk of developing blood clots and subsequent stroke, following final guidance from NICE. Dabigatran should only be offered after a discussion over its risks and benefits in comparison with warfarin.
 http://www.nice.org.uk/newsroom/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s